Evidence has shown that transfusion-dependent patients experience hypogonadotropic hypogonadism, mainly due to ferritin accumulation in the anterior pituitary, suppressing gonadotropin-level pathways especially those producing growth hormone (GH) and thyroid-stimulating hormone (TSH) [276]. The gene discussed is GH1; the disease is hypogonadotropic hypogonadism.